支持和反对瘤微环境:以纳米粒子为基础的积极癌症治疗策略
Soroush Karimi1, Roksana Bakhshali2, Soheil Bolandi3
1Nano Drug Delivery Research Center, Health Technology Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran.
Materials today. Bio
|March 24, 2025
概括
纳米医学可以重新编程瘤微环境 (TME),以克服癌症治疗抵抗力. 本综述探讨了纳米粒子策略,以提高药物输送和免疫反应,以获得更有效的癌症疗法.
科学领域:
- 在瘤学瘤学.
- 纳米技术纳米技术
- 生物医学工程 生物医学工程
背景情况:
- 瘤微环境 (TME) 是有效治疗癌症的重要障碍,促进药物耐药性和瘤进展.
- 目前的癌症疗法面临的局限性是由于TME的复杂性和免疫抑制性.
研究的目的:
- 提供纳米医学的作用在调节TME增强癌症治疗的全面概述.
- 探索利用纳米粒子克服治疗耐药性和改善治疗结果的新策略.
主要方法:
- 对TME调制中纳米医学应用的当前文献的综述.
- 分析基于纳米粒子的策略,针对TME组件,如氧气水平,酸度和细胞外矩阵.
- 检查瘤内的纳米粒子介导免疫调节.
主要成果:
- 纳米粒子可以被设计为改变TME特征,提高药物透率和疗效.
- 基于纳米粒子的方法可以通过减少免疫抑制来增强抗瘤免疫反应.
- 调节TME相互增强纳米医学的有效性,创造协同治疗潜力.
结论:
- 在癌症治疗中,纳米医学提供了有希望的策略来克服TME诱导的抗药性.
- 使用纳米颗粒的向TME调制可以显著提高化学疗法和放射疗法等现有疗法的疗效.
- 未来的研究应该专注于利用和克服TME,使用基于纳米粒子的先进方法来精确治疗癌症.
更多相关视频
09:01Magnetic-, Acoustic-, and Optical-Triple-Responsive Microbubbles for Magnetic Hyperthermia and Pothotothermal Combination Cancer Therapy
Published on: May 22, 2020
3.0K
08:02Isolation of Primary Cancer-Associated Fibroblasts from a Syngeneic Murine Model of Breast Cancer for the Study of Targeted Nanoparticles
Published on: May 14, 2021
5.4K
相关概念视频
The Tumor Microenvironment
6.5K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.5K
Tumor Immunotherapy
450
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
450
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Cancer Therapies
7.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.5K
Drugs that Stabilize Microtubules
2.0K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K
